What are the PODS criteria for acute bacterial rhinosinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

PODS Criteria for Acute Bacterial Rhinosinusitis

The IDSA guideline defines three clinical presentations (any one of which qualifies) for diagnosing acute bacterial rhinosinusitis: (1) Persistent symptoms ≥10 days without improvement, (2) Severe symptoms with high fever (≥39°C) and purulent nasal discharge or facial pain for 3-4 consecutive days at illness onset, or (3) "Double-sickening" with worsening symptoms after initial improvement from a viral URI at 5-6 days. 1

The Three PODS Criteria

The acronym PODS stands for:

  • Persistent symptoms
  • Onset with severe symptoms
  • Double-sickening (worsening)
  • Symptoms

1. Persistent Presentation

  • Symptoms lasting ≥10 days without any evidence of clinical improvement
  • This is the most common presentation distinguishing bacterial from viral rhinosinusitis
  • Look for: nasal congestion, purulent discharge, facial pressure/pain, cough that persists beyond the typical 7-10 day viral URI course 1

2. Severe Presentation

  • High fever ≥39°C (102°F) AND
  • Purulent nasal discharge OR facial pain
  • Must last for at least 3-4 consecutive days at the beginning of illness
  • This represents an acute severe bacterial infection from the outset 1

3. Double-Sickening (Worsening) Presentation

  • Initial viral URI symptoms that were improving at 5-6 days
  • Then new onset or worsening of:
    • Fever
    • Headache
    • Increased nasal discharge
  • This biphasic pattern suggests secondary bacterial superinfection 1

Strength of Evidence

The IDSA guideline rates these criteria as strong recommendations based on low-moderate quality evidence 1. While the evidence quality is not robust, the desirable effects of appropriate antibiotic use clearly outweigh the risks when these criteria are met, making this a strong recommendation applicable to most patients in most circumstances.

Clinical Application

Meeting ANY ONE of these three criteria is sufficient to diagnose acute bacterial rhinosinusitis and consider antibiotic therapy 1. You do not need all three—just one qualifies the patient. Recent evidence confirms that antibiotics should be considered for patients with 3 or more days of severe symptoms, significant worsening after 3-5 days, or 7 or more days of symptoms 2.

Important Caveat

Note that "PODS" in the literature also refers to "Pediatric Odontogenic Sinusitis"—a completely different entity involving dental-origin sinus infections in children 3. Do not confuse this with the PODS mnemonic for acute bacterial rhinosinusitis criteria.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.